Metropolis Healthcare Limited has announced an interim dividend of INR 4 per equity share for the financial year 2025-26, as approved by the Board of Directors during their meeting on November 4, 2025. This decision comes alongside the approval of the company's un-audited standalone and consolidated financial results for the quarter and half-year ending September 30, 2025. The record date for the dividend payment is set for November 11, 2025, and shareholders can expect the dividend to be dispatched within 30 days following the declaration. The meeting, which started at 2:15 PM and concluded at 5:00 PM IST, was focused on the company's financial performance and shareholder returns.

The financial results show promising growth with revenue from operations reaching INR 35,571.32 lakhs for the quarter, compared to INR 32,363.24 lakhs in the same period last year. The total income for the half-year amounted to INR 68,464.43 lakhs, reflecting the company’s strong operational capabilities. Profit before tax for the quarter stood at INR 6,211.86 lakhs, while profit for the period was reported at INR 4,663.28 lakhs. Earnings per share for the quarter was INR 9.00, reinforcing the company's consistent profitability and solid financial footing.

Additionally, the announcement outlined several business acquisitions and operational developments. Metropolis Healthcare has been active in expanding its market presence through strategic acquisitions, including the purchase of various pathology laboratories. Notably, the company has also dealt with tax assessments from the Income Tax Department, reducing its previous liabilities significantly by addressing rectifications and appeals favorably. This proactive approach, combined with robust financial results, positions Metropolis Healthcare as a strong player in the healthcare sector, poised for future growth and enhanced shareholder value.